A new study has linked a type of injectable birth control with meningioma. The manufacturer says the claims are “without ...

A well-known injectable birth control method is under fire after multiple studies linked it to a specific kind of brain tumor, and now, lawsuits are piling up against the drugmaker. […] The post ...

The hormonal treatments cyproterone acetate and medroxyprogesterone acetate are the most effective at reducing hot flushes, a common side-effect in men being treated with hormone therapy for ...

Nearly half of women using depot medroxyprogesterone acetate (DMPA), commonly known as the birth control shot, will experience high bone mineral density (BMD) loss in the hip or lower spine within ...

New research suggests that use of depot medroxyprogesterone acetate may be associated with an increased risk for fracture in women, particularly in those with longer treatment duration and ...

Sixty patients were entered (thalidomide:medroxyprogesterone = 29:31; median age, 59 [thalidomide], 60 [medroxyprogesterone]; No. of patients assessable for response, 22 [thalidomide], 26 ...

Use of the injectable contraceptive depot medroxyprogesterone acetate (MPA), common in areas such as sub-Saharan Africa with high HIV-1 prevalence, is associated with suppression of the immune ...

Men with prostate cancer who reported having significant hot flushes during androgen suppression treatment had a better hormonal response with cyproterone and medroxyprogesterone compared with ...

Medroxyprogesterone acetate injection is approved by Drug Regulatory Authorities as sustained female contraceptive. It is injected deep into large muscle mass, preferably gluteal muscle, with dosing ...